Home Business Pfizer to buy 8.1 percent stake in Valneva

Pfizer to buy 8.1 percent stake in Valneva

by Kolkata Today

Healthcare giant Pfizer has agreed to invest 90.5 million euros to buy an 8.1% percent stake in French vaccines company , as the companies announced developments in their partnership to tackle the Lyme disease.

Pfizer will buy the stake in Valneva, which is also working on its COVID-19 vaccine, at a price of 9.49 euros per share, via a reserved capital increase.

Shares in Valneva rose sharply, surging by 14.5% in early session trading to 9.09 euros.

Valneva will use the proceeds from Pfizer’s equity investment to support its Phase 3 development contribution to the Lyme disease program.


Pfizer  Valneva Covid19 Vaccine Health Administration Kolkata

Related Articles

Leave a Comment